Prevention of renal disease progression and renal replacement therapy in emerging countries

Artificial Organs

Volumn 30, Issue 7, 2006, Pages 501-509

  Hafez, Mohamed H ^a   Abdellatif, Dina A ^a   Elkhatib, Mohamed M ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Chronic kidney disease; Developing countries; End stage renal disease; Modalities; Prevention; Renal replacement therapy; Screening programs; Transplantation

Indexed keywords

BUDGET CONTROL; DIAGNOSIS; DISEASE CONTROL; DISEASES;

CHRONIC KIDNEY DISEASE; DISEASE PROGRESSION; EMERGING COUNTRIES; END-STAGE RENAL DISEASE; MODALITY; PREVENTION; RENAL DISEASE; RENAL REPLACEMENT THERAPIES; SCREENING PROGRAMS; TRANSPLANTATION;

DEVELOPING COUNTRIES;

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BICARBONATE; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IRON; PHOSPHORUS; PROTEIN; RECOMBINANT ERYTHROPOIETIN; VITAMIN D;

ANEMIA; BLOOD PRESSURE; CADAVER DONOR; CHRONIC KIDNEY DISEASE; DEVELOPING COUNTRY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIALYSIS; DISEASE COURSE; DYSLIPIDEMIA; EXERCISE; GLOMERULUS FILTRATION RATE; HEALTH BEHAVIOR; HEALTH PROGRAM; HUMAN; HYPERTENSION; INDIA; KIDNEY DISEASE; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; NORTH AFRICA; OBESITY; ORGAN TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN RESTRICTION; QUESTIONNAIRE; RENAL REPLACEMENT THERAPY; REVIEW; SAUDI ARABIA; SCREENING TEST; SMOKING CESSATION; SOUTH AFRICA; SOUTH AND CENTRAL AMERICA;

EID: 33745501993     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2006.00251.x     Document Type: Review

References (30)

1. Lawrence A, Keith N, David P. The disproportionate burden of kidney disease in those who can least afford it. Kidney Int 2005 68 : S1 S3.
2. Almaguer M, Herrera R, Alfonso J, Magrans C, Manalich R, Martinez A. Primary health care strategies for the prevention of end-stage renal disease in Cuba. Kidney Int 2005 68 : S4 S10.
3. Arrigo S, Giuseppe R. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int 2005 68 : S7 S10.
4. Barsoum RS. End-stage renal disease in North Africa. Kidney Int 2003 63 (Suppl. 83 111 4.
5. Saraladevi N. End-stage renal disease in sub-Saharan and South Africa. Kidney Int 2003 63 : S119 22.
6. Bellorin-Font E, Pernalete N, Meza J, Milanes CL, Carlini RG. Access to and coverage of renal replacement therapy in minorities and ethnic groups in Venezuela. Kidney Int 2005 68 : S18 S22.
7. Shaheen FA, Al-Khader AA. Preventive strategies of renal failure in the Arab world. Kidney Int 2005 68 : S37 40.
8. Ibrahim MM, Rizk H, Appel LJ, et al. Hypertension prevalence, awareness, treatment and control in Egypt. Hypertension 1995 26 : 886 90.
9. Ibrahim MM. Future of research in hypertension in developing countries. Health J 1996 2 : 202 5.
10. Agarwal SK. Chronic kidney disease and its prevention in India. Kidney Int 2005 68 : S41 5.
11. Sakhuja V, Sud K. End-stage renal disease in India and Pakistan: burden of disease and management issues. Kidney Int 2003 63 (Suppl. 83 115 8.
12. Kher V. End-stage renal disease in developing countries. Kidney Int 2002 62 : 350 62.
13. Bello AK, Nwankwo E, El Nahas AM. Prevention of chronic kidney disease: a global challenge. Kidney Int 2005 68 : S11 7.
14. Maschio G, Alberti D, Janin G, et al. Effect of the angiotensin- converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996 334 : 939 45.
15. Praga M, Hernández E, Montoyo C, et al. Long-term beneficial effects of ACE inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 1992 20 : 240 8.
16. Praga M. Slowing the progression of renal failure. Kidney Int 2002 61 : S18 22.
17. Praga M, Hernández E, Andres A, et al. Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron 1995 70 : 35 41.
18. Ritz E, Benck U, Franek E, et al. Effects of smoking on renal hemodynamics in healthy volunteers and in patients with glomerular disease. J Am Soc Nephrol 1998 9 : 1798 804.
19. Yu HC, Burrell LM, Black MJ, et al. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 1998 98 : 2621 8.
20. Lamonte MJ, Yanowitz FG. Aerobic exercise for lowering blood pressure: a metaanalysis. Clin J Sport Med 2002 12 : 40.
21. Laaksonen DE, Lindstrom J, Lakka TA, et al. Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study. Diabetes 2005 54 : 158 65.
22. Mani M. Experience with a program for prevention of chronic renal failure in India. Kidney Int 2005 67 : S75 8.
23. Tan CC, Chan CM, Ho CK, Wong KS, Lee EJ, Woo KT. Health economics of renal replacement therapy: perspectives fro Singapore. Kidney Int 2005 67 : S19 22.
24. National Kidney Foundation. K/DOQI Guidelines for bone metabolism. Available at http://www.kidney.org/professionals/kdqi/guidelines_bone/Guide6. htm. Accessed May 25, 2006.
25. Katz I. International aid and medical practice in the less-developed world: doing it right, what can renal organizations learn? Kidney Int 2005 68 : S60 5.
26. National Kidney Foundation. cyberNephrology Center. Available at: http://www.cybernephrology.org/education/education.htm. Accessed February 1, 2006.
27. Katikireddi SV. HINARI: bridging the global information divide. BMJ 2004 328 : 1190 3.
28. Kher V. End-stage renal disease in developing countries. Kidney Int 2002 62 : 350 62.
29. Rizvi SA, Naqvi SA, Hussain Z, et al. Renal transplantation in developing countries. Kidney Int 2003 63 (Suppl. 83 96 100.
30. Keshaviah P. Resource limitations and strategies for the treatment of uremia. Blood Purificat 2001 19 : 44 52.